Topical Corticosteroid in Foam Vehicle Offers Comparable Coverage Compared with Traditional Vehicles

    Steven R. Feldman, Namrata Sangha, V. Setaluri
    Studysummary This study found that betamethasone valerate in a foam vehicle has comparable total coverage to traditional topical corticosteroid vehicles, despite less coverage per unit of foam.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The study compared the coverage and effectiveness of a new betamethasone valerate foam vehicle with traditional topical corticosteroid preparations (cream, lotion, gel, and solution) for treating scalp dermatoses. The foam vehicle, which leaves no residue, had 9-12 times more fingertip units (FTUs) per 100 g than cream or gel and 2.3-2.8 times more than lotion or solution. Although each FTU of foam covered a smaller area, the total coverage area for 100 g of foam was comparable to that of the traditional vehicles, making the foam vehicle an effective alternative.
    Discuss this study in the Community →